Article

Visions

Benchmarking and Outcome Development Q&A

The evaluation of occupational health services should be guided by the analysis of the work processes and their objectives. At the professional level, the results of the evaluation should contribute to the improvement of the quality of our services, and at the scientific level, evaluation research should provide the best evidence for occupational health practice.

Click to view

Benefits of NAOHP Certification Q&A

How do we let the market know what “to be certified” means? In 1991, NAOHP developed Program Standards. In 2002, NAOHP developed a plan to establish occupational health standards of practice and gained recognition for professionals in the field of occupational health.

Click to view

Integrating Occupational Health and Urgent Care Q&A

What are the benefits of doing this? Our hospital says it will cut into our ED business. The development of a hub is a great advantage to coordinating the multisite blended clinic. The emergency department did not have decreased volumes. It realized a decrease in wait times and provided more awareness of what to treat in the ED and the urgent care clinic.

Click to view

Benchmarking and Outcome Development Q&A

What outcomes are employers looking for from OHS? The development of employer dashboards looks at compliance, controlling health costs, evaluating experience, measuring employee outcomes. Are people getting the services done to control their health needs? They’re looking for access to appointments, compliance to return to work plan, looking at percent of positive tests to all testing, evaluating DOT compliance, early intervention, and savings on timely return to work.

Click to view

Operational Efficiencies Q&A

Define best practices first. NAOHP has six pillars of excellence. These are administrative and organizational, operational infrastructure, staffing resources, clinical services, quality monitoring, and sales and marketing. 

Click to view

Are You Confused or Just High?

Even though marijuana is legal in many states, we know that for federal programs, including DOT, it is considered a Schedule I drug and is therefore prohibited from use by commercial drivers.

Click to view